Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ASENSUS SURGICAL, INC.TRXC · Entity 88098 | Director · President and CEO | May 14, 2019 | May 15, 2019 |
| Humacyte, Inc.HUMA · Entity 6478 | Director | June 12, 2025 | June 16, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ASENSUS SURGICAL, INC.
Report date May 14, 2019 · Filed May 15, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 924,359 |
Reported balance
After 2019-05-14 transaction · row 1
1 source rowRow 1 · 2019-05-14 · Exercise / conversion · Acquired 71,943 · Balance 924,359 |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $1.39 · Expires 2028-02-07 | Direct | 928,057 |
Reported balance
After 2019-05-14 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-05-14 · Exercise / conversion · Disposed 71,943 · Balance 928,057 |
Humacyte, Inc.
Report date June 12, 2025 · Filed June 16, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.41 · Expires 2035-06-12 | Direct | 80,000 |
Reported balance
After 2025-06-12 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-06-12 · Grant · Acquired 80,000 · Balance 80,000 F1: The first 25% of the option becomes exercisable on June 12, 2026, after which 1/48 of the option will become exercisable on the 12th of each month through June 12, 2029. |
Filing footnotes · ownership attribution and instrument terms
F1: The first 25% of the option becomes exercisable on June 12, 2026, after which 1/48 of the option will become exercisable on the 12th of each month through June 12, 2029.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 03, 2017 Filed Jul 6, 2017 21:03 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | GrantRestricted Stock Units · Derivative | 1,500,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-044251 · doc4.xml · derivative · entry 1 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500,000 Underlying: Common Stock · 1,500,000 shares Expires not disclosed F1 · security: Each restricted stock unit represents a right to receive one share of TransEnterix, Inc. (the "Registrant") common stock. F2 · derivative.exercise_date: Forfeiture restrictions will lapse as to 1/3rd of the Restricted Stock Units on each of the first three anniversaries of the date of grant, as long as the Reporting Person remains in the employ of the Registrant. The lapse of forfeiture restrictions may accelerate on certain events as set forth in an employment agreement or the Incentive Plan. F2 · derivative.expiration_date: Forfeiture restrictions will lapse as to 1/3rd of the Restricted Stock Units on each of the first three anniversaries of the date of grant, as long as the Reporting Person remains in the employ of the Registrant. The lapse of forfeiture restrictions may accelerate on certain events as set forth in an employment agreement or the Incentive Plan. Read SEC document |
| February 04, 2017 Filed Feb 6, 2017 12:26 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 33,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007994 · doc4.xml · derivative · entry 6 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,333 Underlying: Common Stock · 33,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the Registrant's common stock. F5 · derivative.exercise_date: Forfeiture restrictions will lapse as to 1/3rd of the restricted stock units on February 4 of each of the first three years following the date of grant, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan. F5 · derivative.expiration_date: Forfeiture restrictions will lapse as to 1/3rd of the restricted stock units on February 4 of each of the first three years following the date of grant, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan. Read SEC document |
| February 04, 2017 Filed Feb 6, 2017 12:26 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionRestricted Stock Units · Derivative | 40,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007994 · doc4.xml · derivative · entry 5 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,111 Underlying: Common Stock · 40,556 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the Registrant's common stock. F5 · derivative.exercise_date: Forfeiture restrictions will lapse as to 1/3rd of the restricted stock units on February 4 of each of the first three years following the date of grant, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan. F5 · derivative.expiration_date: Forfeiture restrictions will lapse as to 1/3rd of the restricted stock units on February 4 of each of the first three years following the date of grant, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan. Read SEC document |
| February 04, 2017 Filed Feb 6, 2017 12:26 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Tax withholdingCommon Stock | 27,590 | $1.42 | $39,177.80 |
DisclosureSEC source: 0001209191-17-007994 · doc4.xml · nonDerivative · entry 2 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,309 F1 · kind: This transaction represents the payment of a tax liability on the lapse of forfeiture restrictions on a derivative security and acquisition of the underlying shares. Read SEC document |
| February 04, 2017 Filed Feb 6, 2017 12:26 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | Exercise / conversionCommon Stock | 73,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007994 · doc4.xml · nonDerivative · entry 1 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,899 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 12:26 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | GrantRestricted Stock Units · Derivative | 158,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-007994 · doc4.xml · derivative · entry 4 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 158,000 Underlying: Common Stock · 158,000 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of the Registrant's common stock. F4 · derivative.exercise_date: Forfeiture restrictions will lapse on the restricted stock units in three equal annual installments of 52,667, 52,667 and 52,666 on February 4, 2018, 2019 and 2020, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan. F4 · derivative.expiration_date: Forfeiture restrictions will lapse on the restricted stock units in three equal annual installments of 52,667, 52,667 and 52,666 on February 4, 2018, 2019 and 2020, as long as the Reporting Person remains in the employ of the Registrant, subject to acceleration as set forth in the Incentive Plan. Read SEC document |
| February 02, 2017 Filed Feb 6, 2017 12:26 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | GrantStock Option · Derivative | 710,000 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0001209191-17-007994 · doc4.xml · derivative · entry 3 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 710,000 Underlying: Common Stock · 710,000 shares Expires 2027-02-02 F2 · derivative.exercise_date: Vests 25% on the first anniversary of the date of grant and 1/48th of the entire award monthly on the vesting date anniversary for 36 months, subject to acceleration as set forth in the Incentive Plan. Read SEC document |
| October 25, 2016 Filed Oct 27, 2016 18:01 UTC | ASENSUS SURGICAL, INC. TRXC · Entity 88098 | GrantStock Option · Derivative | 340,000 | $0.00 Strike: $1.53 | $0.00 |
DisclosureSEC source: 0001209191-16-147185 · doc4.xml · derivative · entry 1 Pope Todd · CIK 0001584367 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 340,000 Underlying: Common Stock · 340,000 shares Expires 2026-10-25 F1 · derivative.exercise_date: Vests 25% on the first anniversary of the date of grant and thereafter 1/48th of the entire award monthly for 36 months. The outstanding equity awards are subject to acceleration provisions set forth in an Employment Agreement between the Registrant and the Reporting Person in connection with termination of employment due to a Change in Control. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.